Our objective was to determine whether colorectal cancer tissue synthe
sizes and secretes biologically active gastrins resulting in a rise of
gastrin levels in patients with adenocarcinoma of the colon. Blood sa
mples for gastrin determination were taken from the artery feeding, an
d from the vein draining colon tumors, from a vein draining an uninvol
ved colon segment and from a peripheral vein. Tissue gastrin levels we
re measured in tumor tissues and normal mucosa taken by colonoscopic b
iopsy from colon cancer patients and healthy controls. The setting was
a university hospital research laboratory. We had seventeen patients
with colorectal cancer and 23 controls. No significant difference was
found in peripheral venous blood gastrin levels between the cancer and
the control groups. Serum gastrin concentration was not significantly
different in the arterial blood which supplied the tumor area, the ve
nous blood draining the tumor, the ''uninvolved'' mucosa or the contro
l normal epithelium. Cancer tissue gastrin levels were lower than thos
e measured in biopsies of uninvolved mucosa from cancer patients and n
ormal controls. The present results show no rise of gastrin blood leve
ls in patients with colon cancer, nor any evidence of gastrin-increase
d synthesis by the tumors.